Zhejiang Haishen Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 20th meeting of the third board of directors on April 27, 2026, where it reviewed and approved the proposal on "Election of the Chairman of the Third Board of Directors and the Director Representing the Company in Executing Company Affairs." The specific content can be found in the announcement titled "Announcement on Resignation of Chairman and Election of Chairman, Director Representing the Company in Executing Company Affairs, Change of Legal Representative, and Supplementary Election of Members of the Board of Directors' Strategy and Sustainable Development Committee" (Announcement No. 2026-016), disclosed by the Company on April 28, 2026, in the Securities Times, Shanghai Securities Journal, and the Giant Tide Information Network (www.cninfo.com.cn). Recently, the Company complet
001367SZSE
Announcement on Completing the Registration of Legal Representative Change and Reissuing Business License
✨ AI Summary
Zhejiang Haishen Pharmaceutical Co., Ltd. announced the completion of the registration change for its legal representative, changing from Wang Shiyue to Wang Yuxiao. This decision was approved during the 20th meeting of the third board of directors held on April 27, 2026. The company has received a new business license reflecting this change, with no other alterations to the license's content.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.